Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2LPN

Solution Structure of N-Terminal domain of human Conserved Dopamine Neurotrophic Factor (CDNF)

Summary for 2LPN
Entry DOI10.2210/pdb2lpn/pdb
Related2w50
NMR InformationBMRB: 18269
DescriptorCerebral dopamine neurotrophic factor (1 entity in total)
Functional Keywordsnerve growth factor, neurotrophic factor, intercellular signaling protein, nerve tissue protein, neuronal growth-associated, hormone
Biological sourceHomo sapiens (human)
Cellular locationSecreted: Q49AH0
Total number of polymer chains1
Total formula weight11964.95
Authors
Latge, C.,Cabral, K.M.S.,Foguel, D.,Pires, J.R.M.,Almeida, M.S. (deposition date: 2012-02-15, release date: 2013-02-20, Last modification date: 2024-10-30)
Primary citationLatge, C.,Cabral, K.M.,Almeida, M.S.,Foguel, D.
(1)H-, (13)C- and (15)N-NMR assignment of the N-terminal domain of human cerebral dopamine neurotrophic factor (CDNF).
Biomol.Nmr Assign., 7:101-103, 2013
Cited by
PubMed Abstract: Parkinson's disease (PD) is a neurodegenerative disorder that is caused by the death of midbrain dopaminergic neurons. Current therapies for PD do not halt the neurodegeneration nor repair the affected neurons. Therefore, search for novel neurotrophic factors (NTF) for midbrain dopaminergic neurons, which could be used in novel therapeutic approaches, is highly wanted. In 2007, a potent NTF for dopaminergic neurons was described as the conserved dopamine neurotrophic factor (CDNF). Single doses of this protein protect and restore dopaminergic neurons in experimental models of PD. CDNF has two domains; an N-terminal saposin-like domain, which may bind to membranes; and a presumably intrinsically unstructured C-terminal which contains an internal cysteine bridge in a CXXC motif similar to that of thiol/disulphide oxidoreductases and isomerases, and may thus reduce the endoplasmic reticulum stress caused by incorrectly folded proteins. We show for the first time the nuclear magnetic resonance assignment of N-terminal domain of recombinant CDNF (residues 1-105) by solution 2D and 3D NMR spectroscopy. We were able to obtain a nearly complete resonance assignment, which is the first step toward the solution structure determination of this neurotrophic factor.
PubMed: 22528768
DOI: 10.1007/s12104-012-9388-8
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon